SALT
LAKE CITY, May 3, 2022 /PRNewswire/ --
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or
"Co-Dx,"), a molecular diagnostics company with a unique, patented
platform for the development of molecular diagnostic tests,
announced today that it will be hosting a booth at the Medical Fair
Brasil, held May 3-6, 2022, at the
Expo Center Norte in São Paulo, Brazil.
The international exhibition on hospital, diagnostic,
pharmaceutical, medical and rehabilitation equipment and supplies
is described on its website as a communication channel with
the healthcare sector where companies present their products,
innovations and services with the purpose of supplying and
transforming the healthcare chain. With visitors including hospital
and laboratory managers and administrators, laboratory technicians,
clinicians, and physicians, Co-Dx believes that the fair will
provide opportunities for Company representatives and distributors
to introduce Company products directly to those individuals
responsible for making purchasing decisions for their institutions.
Attendees interested in learning more about the Company and its
products, including its upcoming point-of-care and at-home rapid
PCR diagnostics platform, are invited to visit Booth # 204.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
Utah corporation, is a molecular
diagnostics company that develops, manufactures and markets
state-of-the-art diagnostics technologies. The Company's technology
is utilized for tests that are designed using the detection and/or
analysis of nucleic acid molecules (DNA or RNA). The Company also
uses its proprietary technology to design specific tests to locate
genetic markers for use in industries other than infectious disease
and license the use of those tests to specific customers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medical-fair-brasil-2022-in-sao-paulo-on-may-3-6-301538513.html
SOURCE Co-Diagnostics